Concepedia

David D. Kim

DD

6

Publications

192

Citations

6

H-Index

2000

Active since

Affiliations

University of California, Los Angeles(Current)

Cancer Center of Kansas

Massachusetts General Hospital

David D. Kim is an author at University of California, Los Angeles specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2000–2023

6

Publications

6

Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type

Susan M. Swetter, Frank W. Chen, David D. Kim et al. · Journal of the American Academy of Dermatology · 2015 · 74 citations

, , +9

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.

Sara A. Hurvitz, Lisa S. Wang, David W. Chan et al. · Journal of Clinical Oncology · 2022 · 37 citations

, , +15

Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

Aditya Bardia, Sara A. Hurvitz, Michael F. Press et al. · Cancer Research · 2023 · 29 citations

, , +17

Platelet-Activating Factor Modulates Microvascular Dynamics through Phospholipase C in the Hamster Cheek Pouch

David D. Kim, Marı ́a M. Ramı ́rez, Walter N. Dura ́n · Microvascular Research · 2000 · 22 citations

, , +13

Anatomically Realistic Patient-Specific Surgical Planning of Complex Congenital Heart Defects Using MRI and CFD

Kartik S. Sundareswaran, Diane de Zélicourt, Kerem Pekkan et al. · Conference proceedings · 2007 · 16 citations

Rows per page

1–5 of 6